Why Pharma’s Real Supply Chain Risk Starts Before the API
Most pharma risk programs stop at the API supplier. The real exposure often sits one tier deeper, in a single shared key…
Read article
Category
Life Sciences
Pharmaceutical and life sciences supply chain risk management. Analysis of API sourcing risk, cold chain disruption, GMP supplier compliance, medical device supply chain risk, and regulatory requirements for life sciences procurement teams.
Why Medical Device Supply Chains Have a Taiwan Problem
Medical devices depend on Taiwan and South Korea chips. Here's the semiconductor supply chain risk procurement teams need to monitor in real…
Read article
Medical Device Supplier Compliance Enters the QMSR Era
Medical device supplier compliance now falls under direct FDA scrutiny. See what QMSR and EU MDR Article 10a mean for procurement teams.
Read article
Pharma Supply Chain Contract Risk: Why Renewals Need Live Data
Pharma supply chain contract risk builds up between renewal cycles. See why live supplier data, not quarterly snapshots, should drive API sourcing…
Read article
Why Medical Device Supply Chain Visibility Stops at Tier 1
Medical device supply chain visibility often stops at tier 1, hiding the sub-tier risk behind recalls like Medline's 2026 neuro sponge shortage.
Read article
Pharma Supply Chain Risk Hides Beneath Your API Suppliers
Multiple API suppliers won't stop a drug shortage if they share one key starting material source. What the 2026 pharma supply chain…
Read article
The Real Cost of Reactive Medical Device Supply Chain Risk
Reactive procurement is costing medical device makers millions. See what the Medline recall and FDA shortage list reveal about supply chain risk.
Read article
Pharma Supply Chain Compliance: Why FDA Scrutiny Is Rising
FDA warning letters to API manufacturers rose 59% in FY2025. See what's driving pharma supply chain compliance risk and how procurement can…
Read articleMedical Device Supplier Risk Monitoring Needs Real-Time Data
Quarterly reports miss real-time medical device supplier risk. See why explainable AI monitoring catches financial distress before recalls hit.
Read article
Pharma Supply Chain Risk: The 2026 CPO Leadership Playbook
Pharma supply chain risk is now a board-level exposure. How CPOs can run supplier risk like a finance function in 2026, continuously…
Read article